scholarly journals Chemoimmunotherapy versus immune checkpoint inhibitors monotherapy as first‐line treatment for advanced non‐small cell lung cancer

2022 ◽  
Author(s):  
Alessandro Rizzo
BioDrugs ◽  
2019 ◽  
Vol 33 (2) ◽  
pp. 159-171 ◽  
Author(s):  
Olivier Bylicki ◽  
Helene Barazzutti ◽  
Nicolas Paleiron ◽  
Jacques Margery ◽  
Jean-Baptiste Assié ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document